IP Library Granted Patent US 8,052,996
Granted Patent B2
US 8,052,996 · App. 11/755,494 · Granted Nov 8, 2011

Two-piece, internal-channel osmotic delivery system flow modulator

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,052,996
App. No.
11/755,494
Granted
Nov 8, 2011
Kind
B2
Abstract

An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.

Claims (26)

1. An implantable delivery system for an active agent formulation, comprising:

a reservoir made of an impermeable material;

a first chamber in the reservoir containing an osmotic engine;

a second chamber in the reservoir containing an active agent formulation;

a partition within the reservoir, the partition defining within the reservoir the first chamber containing the osmotic engine and the second chamber containing the active agent formulation;

a semipermeable plug disposed at a first end of the reservoir adjacent the first chamber; and

a flow modulator comprising (i) two pieces, an outer shell and an inner core, and (ii) an internal fluid channel, the flow modulator disposed at a second end of the reservoir adjacent the second chamber, the flow modulator comprising

the outer shell positioned in an opening at the second end of the reservoir, the outer shell comprising an inner surface,

the inner core inserted in the outer shell, the inner core comprising an outer surface, and

the internal fluid channel having a spiral shape defined between the outer shell and the inner core.

2. The implantable delivery system of claim 1 , wherein the fluid channel is formed on the outer surface of the inner core which mates with the inner surface of the outer shell.

3. The implantable delivery system of claim 1 , wherein the fluid channel is formed on the inner surface of the outer shell which mates with the outer surface of the inner core.

4. The implantable delivery system of claim 1 , further comprising a flow insert disposed between the outer shell and inner core, wherein the fluid channel is formed in the flow insert.

5. The implantable delivery system of claim 4 , wherein the outer shell, inner core, and flow insert are made of an inert material.

6. The implantable delivery system of claim 5 , wherein the inert material is a non-metallic material.

7. The implantable delivery system of claim 1 , wherein the outer shell and inner core are made of an inert material.

8. The implantable delivery system of claim 7 , wherein the inert material is a non-metallic material.

9. The implantable delivery system of claim 8 , wherein the material is polyetheretherketone, polyaryletheretherketone, ultra-high molecular weight polyethylene, fluorinated ethylene-propylene, polymethylpentene, or liquid crystal polymers.

10. The implantable delivery system of claim 1 , wherein the outer shell sealingly engages the inner core.

11. The implantable delivery system of claim 1 , wherein the inner core includes an outer shoulder and the outer shell includes an inner shoulder, wherein the outer shoulder and inner shoulder engage to prevent expulsion of the inner core from the outer shell.

12. The implantable delivery system of claim 1 , wherein a length of the fluid channel ranges from 10 to 50 mm.

13. The implantable delivery system of claim 1 , wherein an effective cross-sectional diameter of the fluid channel ranges from 0.1 to 0.5 mm.

14. The implantable delivery system of claim 1 , wherein the active agent formulation comprises interferon-omega.

15. The implantable delivery system of claim 1 , wherein the flow modulator is press-fitted into the opening at the second end of the reservoir.

16. The implantable delivery system of claim 1 , wherein the reservoir comprises titanium or a titanium alloy.

17. The implantable delivery system of claim 1 , wherein the partition comprises a slidable piston.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: INTARCIA THERAPEUTICS, INC.; INTARCIA IRELAND LIMITED
Reel/Frame 052433/0001 →
RELEASE OF SECURITY INTEREST Recorded Jan 29, 2020
From: BAUPOST PRIVATE INVESTMENTS BVIV-3, L.L.C. AS COLLATERAL AGENT
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 051739/0453 →
SECURITY INTEREST Recorded Oct 23, 2019
From: INTARCIA THERAPEUTICS, INC.
To: BAUPOST PRIVATE INVESTMENTS BVIV-3, L.L.C., AS COLLATERAL AGENT
Reel/Frame 050801/0267 →
SECURITY INTEREST Recorded Oct 9, 2019
From: INTARCIA THERAPEUTICS, INC.; INTARCIA IRELAND LIMITED
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 050673/0020 →
RELEASE OF SECURITY INTEREST Recorded Oct 23, 2015
From: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 036942/0544 →
SECURITY AGREEMENT Recorded Nov 14, 2012
From: INTARCIA THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 029299/0678 →
RELEASE OF SECURITY INTEREST Recorded Sep 23, 2011
From: OXFORD FINANCE CORPORATION; SILICON VALLEY BANK
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 026962/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2011
From: LAUTENBACH, SCOTT D.; DE LA SERNA, PEDRO E.; ZAMORA, PAULINE C.; DESJARDIN, MICHAEL A.
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 026722/0045 →
SECURITY AGREEMENT Recorded Sep 8, 2010
From: INTARCIA THERAPEUTICS, INC.
To: OXFORD FINANCE CORPORATION; SILICON VALLEY BANK
Reel/Frame 024953/0525 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2008
From: LAUTENBACH, SCOTT D.; DE LA SEMA, PEDRO E.; ZAMORA. PAULINE C; DESJARDIN, MICHAEL A.
To: ALZA CORPORATION
Reel/Frame 021660/0757 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2007
From: LAUTENBACH, SCOTT D.; DE LA SERNA, PEDRO E.; ZAMORA, PAULINE C.; DESJARDIN, MICHAEL A.
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 020141/0531 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2007
From: ALZA CORPORATION
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 020035/0441 →